In other studies, on patients with ET, patients with the JAK2 mutation exhibited significantly more frequent thrombotic events (p = 0.004), higher haemoglobin levels (p = 0.0003), and leukocyte counts (p < 0.0001) [35,43,44,45]. The gene discussed is JAK2; the disease is essential thrombocythemia.